Acetaminophen overdose: What practitioners need to know

Clinical Liver Disease

Volumn 4, Issue 1, 2014, Pages 17-21

  Bari, Khurram ^a   Fontana, Robert J ^a  

^a UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLCYSTEINE; AMINOTRANSFERASE; IPECAC; PARACETAMOL;

ACETAMINOPHEN OVERDOSE; ACUTE LIVER FAILURE; AMINOTRANSFERASE BLOOD LEVEL; CLINICAL ASSESSMENT; CLINICAL FEATURE; DIAGNOSTIC APPROACH ROUTE; DISEASE CLASSIFICATION; DISEASE SEVERITY; DRUG ABSORPTION; DRUG BLOOD LEVEL; DRUG LABELING; DRUG MISUSE; DRUG MONITORING; DRUG OVERDOSE; DRUG TOLERANCE; HUMAN; INTERNATIONAL NORMALIZED RATIO; LABORATORY DIAGNOSIS; MORTALITY; NOMOGRAM; PALLIATIVE THERAPY; PATIENT EDUCATION; PRESCRIPTION; PRIORITY JOURNAL; PROGNOSIS; REVIEW; SUICIDE; SYMPTOMATOLOGY; TOXIC HEPATITIS; VOMITING;

EID: 84904877458     PISSN: None     EISSN: 20462484     Source Type: Journal    
DOI: 10.1002/cld.373     Document Type: Review

References (12)

1. Nourjah P, Ahmad SR, Karwoski C, Willy M. Estimates of acetaminophen (Paracetomal)-associated overdoses in the United States. Pharmacoepidemiol Drug Saf 2006;15(6):398-405.
2. Myers RP1, Li B, Fong A, Shaheen AA, Quan H. Hospitalizations for acetaminophen overdose: a Canadian population-based study from 1995 to 2004. BMC Public Health 2007;7:143.
3. Larson AM, Polson J, Fontana RJ, et al. Acetaminophen-induced acute liver failure: results of a United States multicenter, prospective study. Hepatology 2005;42(6):1364-1372.
4. Smilkstein MJ, Knapp GL, Kulig KW, Rumack BH. Efficacy of oral N-acetylcysteine in the treatment of acetaminophen overdose. N Engl J Med 1988;319:1557-1562.
5. Davern TJ, James LP, Hinson JA, et al. Measurement of serum acetaminophen-protein adducts in patients with acute liver failure. Gastroenterology 2006;130:687-694.
6. Bateman DN, Dear JW, Thanacoody HK, et al. Reduction of adverse effects from intravenous acetylcysteine treatment for paracetamol poisoning: a randomised controlled trial. Lancet 2014;383(9918):697-704.
7. Stravitz RT, Kramer AH, Davern T, et al. Intensive care of patients with acute liver failure: recommendations of the U.S. acute liver failure study group. Crit Care Med 2007;35:2498-508.
8. Ostapowicz G, Fontana RJ, Schiødt FV, et al. Results of a prospective study of acute liver failure at 17 tertiary care centers in the United States. Ann Intern Med 2002;137(12):947-954.
9. Craig DG, Ford AC, Hayes PC, Simpson KJ. Systematic review: prognostic tests of paracetamol-induced acute liver failure. Aliment Pharmacol Ther 2010;31(10):1064-1076.
10. Bernal W, Wendon J, Rela M, et al. Use and outcome of liver transplantation in acetaminophen-induced acute liver failure. Hepatology 1998;27:1050-1055.
11. Hawton K1, Simkin S, Deeks J, et al. UK legislation on analgesic packs: before and after study of long term effect on poisonings. BMJ 2004;329(7474):1076.
12. Serper M, et al. Effect of enhanced risk communication on patient comprehension of concomitant use warnings for APAP- containing products: A randomized Trial (Abstract). Hepatology 2013;58;1722.